Astmabehandling i almen praksis

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Astmabehandling i almen praksis. / Behrendt, Victor; Hilberg, Ole; Bakker, Vibeke; Ulrik, Charlotte Suppli; Bjerring, Niels; Løkke, Anders.

In: Ugeskrift for Laeger, Vol. 184, No. 2, V03210221, 10.01.2022.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Behrendt, V, Hilberg, O, Bakker, V, Ulrik, CS, Bjerring, N & Løkke, A 2022, 'Astmabehandling i almen praksis', Ugeskrift for Laeger, vol. 184, no. 2, V03210221. <https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-01/v03210221_web.pdf>

APA

Behrendt, V., Hilberg, O., Bakker, V., Ulrik, C. S., Bjerring, N., & Løkke, A. (2022). Astmabehandling i almen praksis. Ugeskrift for Laeger, 184(2), [V03210221]. https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-01/v03210221_web.pdf

Vancouver

Behrendt V, Hilberg O, Bakker V, Ulrik CS, Bjerring N, Løkke A. Astmabehandling i almen praksis. Ugeskrift for Laeger. 2022 Jan 10;184(2). V03210221.

Author

Behrendt, Victor ; Hilberg, Ole ; Bakker, Vibeke ; Ulrik, Charlotte Suppli ; Bjerring, Niels ; Løkke, Anders. / Astmabehandling i almen praksis. In: Ugeskrift for Laeger. 2022 ; Vol. 184, No. 2.

Bibtex

@article{1711b5a37b864145b9b9d531418de2e1,
title = "Astmabehandling i almen praksis",
abstract = "This review describes the current Danish guidelines for inhaled asthma treatment. Monotherapy with short-acting beta-agonists (SABA) taken when needed is no longer recommended in asthma therapy for adults due to safety concerns. The recommended first-line treatment is now inhaled corticosteroids (ICS) taken with formoterol or ICS taken with SABA. The choice of inhaler can have a significant impact on compliance and symptom control, and an individualized approach is therefore needed. Biological treatment may be an alternative to oral corticosteroids in selected patient groups.",
keywords = "Administration, Inhalation, Adrenal Cortex Hormones/therapeutic use, Adult, Anti-Asthmatic Agents/adverse effects, Asthma/drug therapy, Drug Therapy, Combination, Ethanolamines/therapeutic use, Formoterol Fumarate/therapeutic use, General Practice, Humans",
author = "Victor Behrendt and Ole Hilberg and Vibeke Bakker and Ulrik, {Charlotte Suppli} and Niels Bjerring and Anders L{\o}kke",
year = "2022",
month = jan,
day = "10",
language = "Dansk",
volume = "184",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "2",

}

RIS

TY - JOUR

T1 - Astmabehandling i almen praksis

AU - Behrendt, Victor

AU - Hilberg, Ole

AU - Bakker, Vibeke

AU - Ulrik, Charlotte Suppli

AU - Bjerring, Niels

AU - Løkke, Anders

PY - 2022/1/10

Y1 - 2022/1/10

N2 - This review describes the current Danish guidelines for inhaled asthma treatment. Monotherapy with short-acting beta-agonists (SABA) taken when needed is no longer recommended in asthma therapy for adults due to safety concerns. The recommended first-line treatment is now inhaled corticosteroids (ICS) taken with formoterol or ICS taken with SABA. The choice of inhaler can have a significant impact on compliance and symptom control, and an individualized approach is therefore needed. Biological treatment may be an alternative to oral corticosteroids in selected patient groups.

AB - This review describes the current Danish guidelines for inhaled asthma treatment. Monotherapy with short-acting beta-agonists (SABA) taken when needed is no longer recommended in asthma therapy for adults due to safety concerns. The recommended first-line treatment is now inhaled corticosteroids (ICS) taken with formoterol or ICS taken with SABA. The choice of inhaler can have a significant impact on compliance and symptom control, and an individualized approach is therefore needed. Biological treatment may be an alternative to oral corticosteroids in selected patient groups.

KW - Administration, Inhalation

KW - Adrenal Cortex Hormones/therapeutic use

KW - Adult

KW - Anti-Asthmatic Agents/adverse effects

KW - Asthma/drug therapy

KW - Drug Therapy, Combination

KW - Ethanolamines/therapeutic use

KW - Formoterol Fumarate/therapeutic use

KW - General Practice

KW - Humans

M3 - Tidsskriftartikel

C2 - 35023469

VL - 184

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 2

M1 - V03210221

ER -

ID: 326024657